Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people: A position statement of Primary Care Diabetes Europe

Autor: Hambling, C.E., Khunti, K., Cos, X., Wens, J., Martinez, L., Topsever, P., Del Prato, S., Sinclair, A., Schernthaner, G., Rutten, G., Seidu, S.

Publikováno v: In Primary Care Diabetes August 2019 13(4):330-352

Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes

Autor: Schernthaner G, Jarvis S, Lotan C, Prázný M, Wanner C, Wascher TC

Publikováno v: Therapeutics and Clinical Risk Management, Vol Volume 13, Pp 69-79 (2017)

Guntram Schernthaner,1 Sarah Jarvis,2 Chaim Lotan,3 Martin Prázný,4 Christoph Wanner,5 Thomas C Wascher6 1Department of Medicine, Rudolfstiftung Hospital, Vienna, Austria; 2Richford Gate Medical Practice, London, UK; 3Cardiovascular Division, Heart

Externí odkaz: https://doaj.org/article/780d6965c5de457da43e280bebe96a26

Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions

Autor: Sharif, A. ^*, Hecking, M., de Vries, A.P.J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., Marchetti, P., Pacini, G., Ojo, A., Takahara, S., Larsen, J.L., Budde, K., Eller, K., Pascual, J., Jardine, A., Bakker, S.J.L., Valderhaug, T.G., Jenssen, T.G., Cohney, S., Säemann, M.D.

Publikováno v: In American Journal of Transplantation September 2014 14(9):1992-2000

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

Autor: Gerotziafas G. T., Catalano M., Colgan M. -P., Pecsvarady Z., Wautrecht J. C., Fazeli B., Olinic D. -M., Farkas K., Elalamy I., Falanga A., Fareed J., Papageorgiou C., Arellano R. S., Agathagelou P., Antic D., Auad L., Banfic L., Bartolomew J. R., Benczur B., Bernardo M. B., Boccardo F., Cifkova R., Cosmi B., De Marchi S., Dimakakos E., Dimopoulos M. A., Dimitrov G., Durand-Zaleski I., Edmonds M., El Nazar E. A., Erer D., Esponda O. L., Gresele P., Gschwandtner M., Gu Y., Heinzmann M., Hamburg N. M., Hamade A., Jatoi N. -A., Karahan O., Karetova D., Karplus T., Klein-Weigel P., Kolossvary E., Kozak M., Lefkou E., Lessiani G., Liew A., Marcoccia A., Marshang P., Marakomichelakis G., Matuska J., Moraglia L., Pillon S., Poredos P., Prior M., Salvador D. R. K., Schlager O., Schernthaner G., Sieron A., Spaak J., Spyropoulos A., Sprynger M., Suput D., Stanek A., Stvrtinova V., Szuba A., Tafur A., Vandreden P., Vardas P. E., Vasic D., Vikkula M., Wennberg P., Zhai Z., Bikdeli B., Guo Y., Harenberg J., Hu Y., Lip G. Y. H., Roldan V.

Publikováno v: Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2020, 120 (12), pp.1597-1628. ⟨10.1055/s-0040-1715798⟩
Thrombosis and haemostasis, Vol. 120, no. 12, p. 1597-1628 (2020)

COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing risk factors to severe COVID-19 are male sex, underlying cardiovascular d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55f4f5a102cb0bb063d3bcdc3fb1d247
https://pubmed.ncbi.nlm.nih.gov/32920811